Healthcare - Drug Manufacturers - Specialty & Generic - NASDAQ - US
$ 4.44
-2.84 %
$ 405 M
Market Cap
-9.87
P/E
Price Target
Average
116.22%
Revenue Forecast
Estimate
41.55%
EBIT
Estimate
--78.34%
Net Income
Estimate
59.52%
WALL STREET ESTIMATES
Wall Street Analysts Price Targets
Aquestive Therapeutics, Inc.
Wall Street analysts predict an average 1-year price target for AQST of $9.6 , with forecasts ranging from a low of $7 to a high of $12 .
AQST Lowest Price Target
Wall Street Target
7 USD
57.66%
AQST Average Price Target
Wall Street Target
9.6 USD
116.22%
AQST Highest Price Target
Wall Street Target
12 USD
170.27%
REVENUE FORECAST
Revenue Forecast Chart AQST
EBIT FORECAST
EBIT Forecast Chart AQST
NET INCOME FORECAST
Net Income Chart AQST